Cargando…
Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with an overall median 5-year survival rate of 8%. This poor prognosis is because of the development of resistance to chemotherapy and radiation therapy and lack of effective targeted therapies. IκB kinase enhancer (IKBKE) overexpression wa...
Autores principales: | Challa, Sridevi, Husain, Kazim, Kim, Richard, Coppola, Domenico, Batra, Surinder K., Cheng, Jin Q., Malafa, Mokenge P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994835/ https://www.ncbi.nlm.nih.gov/pubmed/32004866 http://dx.doi.org/10.1016/j.tranon.2019.11.009 |
Ejemplares similares
-
Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2021) -
δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis
por: Husain, Kazim, et al.
Publicado: (2017) -
Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIP(s)
por: Francois, Rony A., et al.
Publicado: (2019) -
A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
por: Springett, Gregory M., et al.
Publicado: (2015) -
Murine Pancreatic Adenocarcinoma Reduces Ikaros Expression and Disrupts T Cell Homeostasis
por: Nelson, Nadine, et al.
Publicado: (2015)